MyHealthChecked PLC Related Party Transaction (3339Z)
May 20 2021 - 8:23AM
UK Regulatory
TIDMMHC
RNS Number : 3339Z
MyHealthChecked PLC
20 May 2021
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED
UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014
WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL)
ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A
REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO
BE IN THE PUBLIC DOMAIN.
MyHealthChecked Plc
("MyHealthChecked" or the "Company")
Related Party Transaction
Manufacturing Agreement and Purchase order with EKF Diagnostic
Holdings plc
MyHealthChecked Plc (AIM: MHC), the consumer home-testing
healthcare company, announces that on 20 May 2021 it signed a
Manufacturing Agreement and placed a further purchase order of
GBP1.425m with EKF Diagnostic Holdings plc ("EKF") for
PrimeStore(R) MTM sample collection devices.
This purchase is further to previous announcement of 2 December
2020 (relating to an initial purchase order for sample collection
devices with EKF), and will support the supply of the
MyHealthChecked COVID-19 Sample Collection Kit to the market over
the summer period as travel begins to ramp up. The term of the
contract is until December 2022, and may be terminated at 6 months'
notice after 12 months of the initial term.
Up until 19 May 2021 Adam Reynolds, Chairman of MyHealthChecked,
was a director of EKF. As the terms of the agreement have been
negotiated and agreed during this period, the entering into the
agreement and the placing of the purchase order have been treated
as a related party transaction under the AIM Rules. Having
consulted with SPARK Advisory Partners Limited, the Independent
Directors (those directors other than Mr Reynolds) consider that
the terms of the agreement and purchase order are fair and
reasonable insofar as Shareholders are concerned.
MyHealthChecked plc www.myhealthchecked.com
P enny McCormick , Chief Executive via Walbrook PR
Officer
Maddy Kennedy, Chief Financial
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Oberon Capital Ltd (Broker) Tel: +44 (0)203 179 5344
Mike Seabrook mikeseabrook@oberoninvestments.com
Walbrook PR Ltd (Media & Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
IR)
Paul McManus Mob: +44(0)7980 541 893
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA
and RNA tests, now in development following the acquisition of The
Genome Store in November 2020. The tests will be made available
online, and would be viable for over the counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
Glossary:
PCR: polymerase chain reaction
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCFLFFVEFIIFIL
(END) Dow Jones Newswires
May 20, 2021 09:23 ET (13:23 GMT)
Concepta (LSE:CPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Concepta (LSE:CPT)
Historical Stock Chart
From Apr 2023 to Apr 2024